Home / Research projects / Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE)
Share
Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE)
Project objectives
The project has the general objective of evaluating the safety and efficacy of the drug semaglutide in patients with Alzheimer's disease.
Start and end date
Ongoing
Project Manager
Prof. Vincenzo Di Lazzaro - Principal Investigator